Peptide Initiative
Back to Buserelin

Clinical trials

Every registered trial of Buserelin

31 studies.

Plain-Language Summary

Plain-language reading of the public trial registries.

In short

  • Buserelin has a real but limited body of human research.
  • 31 registered studies in total.
  • None are currently enrolling — this research has already happened.

What kind of research

  • 31 studies actually gave the peptide to volunteers and measured what happened. This is the kind of study that can show whether something works.
  • About 14,723 people took part in those.

A registered trial is a plan, not a result. Registration means a study was declared in advance; it says nothing about whether the peptide worked, and a trial can be registered and then abandoned.

Filter

Showing 31 of 31 trials for Buserelin.

  • 2022-502634-52-00 Temporarily Halted280 enrolled2023

    UTN-01-2022

    Friedrich-Schiller-Universitaet Jena

    prostate cancer

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT05567731 Completed30 enrolled2022

    Effect of GnRH Agonist Treatment Protocols on Ovarian Reserve

    Tanta University

    Intracytoplasmic Sperm Injection · GnRH Agonist · Infertility · Ovarian Reserve

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT05050084 Phase 3Active Not Recruiting2,050 enrolled2021

    Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance Trial

    NRG Oncology

    Prostate Adenocarcinoma

  • NCT04513717 Phase 3Active Not Recruiting2,753 enrolled2021

    Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

    NRG Oncology

    Prostate Adenocarcinoma · Stage III Prostate Cancer AJCC v8 · Stage IVA Prostate Cancer AJCC v8

  • NCT03946722 Phase 4Unknown162 enrolled2020

    Modified Downregulation for Women With Adenomyosis of the Uterus Prior to Frozen-thawed Embryo Transfer.

    University College, London

    Adenomyosis

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT06199960 Phase 3Completed116 enrolled2019

    Dual Ovarian Stimulation (Duostim) and Shanghai Protocols in Poor Ovarian Responders

    Royan Institute

    Assisted Reproductive Techniques

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT05638529 Phase 4Unknown80 enrolled2019

    Dual Trigger" in IVF Patients at High Risk of Ovarian Hyper Stimulation Syndrome

    Mount Sinai Hospital, Canada

    Ovarian Hyperstimulation Syndrome · Infertility, Female

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02703584 Phase 4Completed276 enrolled2016

    Co Administration of GnRH Agonist and hCG for Final Oocyte Maturation

    Mount Sinai Hospital, Canada

    Infertility

  • NCT00749853 Phase 3Suspended165 enrolled2015

    Efficacy of Ovarian Stimulation Based on FSHR Genotype Status

    Medical University of Vienna

    Sterility

  • NCT01980680 Phase 4Completed50 enrolled2014

    The Exogenous Progesterone Free Luteal Phase After GnRHa Trigger - a Pilot Study in Normo-responder IVF Patients

    Peter Humaidan

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT02487823 Phase 1Terminated6 enrolled2014

    Dose Finding Study of BKM 120 in Combination With LH-RH Agonists and Bicalutamide in Men With Non Castrate Metastatic Prostate Cancer

    Institut Paoli-Calmettes

    Non Castrate Metastatic Prostate Cancer

  • NCT02480127 Completed20 enrolled2014

    Molecular Evaluation of Endometrium After Endometrial Injury

    Royan Institute

    Endometrial Injury

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT01816789 Phase 4Terminated194 enrolled2013

    Age Versus Ovarian Reserve Markers Based Therapy in IVF (IVF)/Intracytoplasmic Sperm Injection (ICSI) Cycles

    Andros Day Surgery Clinic

    In Vitro Fertilization · Ovarian Stimulation

  • NCT01636505 Phase 3Unknown200 enrolled2012

    The Results of Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening of Embryos Obtained From GnRH-agonist Long and GnRH-antagonist Ovarian Stimulation Protocol

    European Hospital

    Embryo's Genetic and Chromosomal Quality

  • NCT01546987 Phase 3Completed239 enrolled2012

    Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

    Radiation Therapy Oncology Group

    Prostate Cancer

  • NCT01888744 Phase 4Completed120 enrolled2010

    Preimplantation Genetic Diagnosis (PGD) With Gonadotropin-releasing Hormone (GnRH) Agonist Versus Antagonist

    Universitair Ziekenhuis Brussel

    Reproductive Endocrinology · Fertility · Optimal Stimulation Protocol

  • NCT00936390 Phase 3Completed1,538 enrolled2009

    Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer

    Radiation Therapy Oncology Group

    Prostate Cancer

  • NCT01213147 Phase 4Completed159 enrolled2009

    Mild Stimulation Protocol Versus Microdose Gonadotropin-releasing Hormone Agonist Flare up Protocol in Poor Responders

    Yazd Medical University

    Pregnancy

  • NCT00627406 Phase 4Completed384 enrolled2009

    Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles

    Regionshospitalet Viborg, Skive

    OHSS (Ovarian Hyperstimulation)

  • NCT00823121 Phase 1/2Unknown500 enrolled2008

    Replacement of Fresh Embryo Transfers (ETs) by Frozen Embryo Transfers (FETs) Using Vitrification

    Yazd Research & Clinical Center for Infertility

    In Vitro Fertilization

  • NCT00651326 Phase 3Terminated48 enrolled2008

    Androgen Suppression and Radiation With/Out Docetaxel in High-Risk Localized Prostate Cancer

    NCIC Clinical Trials Group

    Prostate Cancer

  • NCT00823004 Phase 1/2Completed120 enrolled2008

    Antagonist/Letrozole in Poor Responders

    Yazd Research & Clinical Center for Infertility

    Ovarian Stimulation

  • NCT00823602 Phase 3Unknown2 enrolled2008

    Agonist Gonadotropin-Releasing Hormone (GnRH) Versus Antagonist GnRH

    Yazd Research & Clinical Center for Infertility

    Infertility

  • NCT00567580 Phase 3Unknown1,792 enrolled2008

    Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate Cancer

    Radiation Therapy Oncology Group

    Prostate Cancer

  • NCT00830492 Phase 4Completed200 enrolled2008

    Clomiphene Citrate (CC)/Gonadotropin/Gonadotropin Releasing Hormone (GnRH) Antagonist Versus Gonadotropin/GnRH Agonist

    Yazd Research & Clinical Center for Infertility

    Ovarian Stimulation

  • NCT00436319 Phase 4Terminated300 enrolled2006

    Duration of GnRH-analogue Downregulation and Pregnancy Rates

    Aristotle University Of Thessaloniki

    Infertility

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

  • NCT00461916 Phase 4Completed182 enrolled2005

    Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin

    Tehran University of Medical Sciences

    Infertility

  • NCT00054106 Phase 1Completed25 enrolled2002

    Hormone Therapy and OGX-011 Before Radical Prostatectomy in Treating Patients With Prostate Cancer

    NCIC Clinical Trials Group

    Prostate Cancer

  • NCT00003653 Phase 3Completed1,386 enrolled1999

    Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate Cancer

    NCIC Clinical Trials Group

    Prostate Cancer

  • NCT00002633 Phase 3Completed361 enrolled1995

    Hormone Therapy With or Without Surgery or Radiation Therapy in Treating Patients With Prostate Cancer

    NCIC Clinical Trials Group

    Prostate Cancer

  • NCT01819285 Phase 3Completed985 enrolled1990

    Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer

    European Organisation for Research and Treatment of Cancer - EORTC

    Neoplasm, Prostate

    Named in the study description rather than as the headline intervention — often a drug given alongside the one being tested.

Sources: ClinicalTrials.gov, the EU Clinical Trials Information System and ISRCTN, deduplicated so a study registered in more than one registry is counted once. A study is listed when Buserelin is named as an intervention. A registered trial is a plan, not a result — registration says nothing about whether the peptide worked.